Appropriate use criteria in dermatopathology

Initial recommendations from the American Society of Dermatopathology

Claudia I. Vidal, Eric A. Armbrect, Aleodor A. Andea, Angela K. Bohlke, Nneka I. Comfere, Sarah R. Hughes, Jinah Kim, Jessica A. Kozel, Jason B. Lee, Konstantinos Linos, Brandon R. Litzner, Tricia A. Missall, Roberto A. Novoa, Uma Sundram, Brian L. Swick, Maria Yadira Hurley, Murad Alam, Zsolt Argenyi, Lyn M. Duncan, Dirk M. Elston & 12 others Patrick O. Emanuel, Tammie Ferringer, Maxwell A Fung, Gregory A. Hosler, Alexander J. Lazar, Lori Lowe, Jose A. Plaza, Victor G. Prieto, June K. Robinson, Andras Schaffer, Antonio Subtil, Wei Lien Wang

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Appropriate use criteria (AUC) provide physicians guidance in test selection, and can affect health care delivery, reimbursement policy and physician decision-making. Objectives: The American Society of Dermatopathology, with input from the American Academy of Dermatology and the College of American Pathologists, sought to develop AUC in dermatopathology. Methods: The RAND/UCLA appropriateness methodology, which combines evidence-based medicine, clinical experience and expert judgment, was used to develop AUC in dermatopathology. Results: With the number of ratings predetermined at 3, AUC were developed for 211 clinical scenarios involving 12 ancillary studies. Consensus was reached for 188 (89%) clinical scenarios, with 93 (44%) considered “usually appropriate,” 52 (25%) “rarely appropriate” and 43 (20%) “uncertain appropriateness.”. Limitations: The methodology requires a focus on appropriateness without comparison between tests and irrespective of cost. Conclusions: The ultimate decision of when to order specific test rests with the physician and is one where the expected benefit exceeds the negative consequences. This publication outlines the recommendations of appropriateness—AUC for 12 tests used in dermatopathology. Importantly, these recommendations may change considering new evidence. Results deemed “uncertain appropriateness” and where consensus was not reached may benefit from further research.

Original languageEnglish (US)
Pages (from-to)563-580
Number of pages18
JournalJournal of Cutaneous Pathology
Volume45
Issue number8
DOIs
StatePublished - Aug 1 2018

Fingerprint

Physicians
Consensus
Evidence-Based Medicine
Decision Making
Delivery of Health Care
Costs and Cost Analysis
Research
Pathologists

Keywords

  • ancillary studies
  • appropriate use criteria
  • dermatopathology
  • evidence-based medicine
  • expert rating

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology
  • Dermatology

Cite this

Vidal, C. I., Armbrect, E. A., Andea, A. A., Bohlke, A. K., Comfere, N. I., Hughes, S. R., ... Wang, W. L. (2018). Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology. Journal of Cutaneous Pathology, 45(8), 563-580. https://doi.org/10.1111/cup.13142

Appropriate use criteria in dermatopathology : Initial recommendations from the American Society of Dermatopathology. / Vidal, Claudia I.; Armbrect, Eric A.; Andea, Aleodor A.; Bohlke, Angela K.; Comfere, Nneka I.; Hughes, Sarah R.; Kim, Jinah; Kozel, Jessica A.; Lee, Jason B.; Linos, Konstantinos; Litzner, Brandon R.; Missall, Tricia A.; Novoa, Roberto A.; Sundram, Uma; Swick, Brian L.; Hurley, Maria Yadira; Alam, Murad; Argenyi, Zsolt; Duncan, Lyn M.; Elston, Dirk M.; Emanuel, Patrick O.; Ferringer, Tammie; Fung, Maxwell A; Hosler, Gregory A.; Lazar, Alexander J.; Lowe, Lori; Plaza, Jose A.; Prieto, Victor G.; Robinson, June K.; Schaffer, Andras; Subtil, Antonio; Wang, Wei Lien.

In: Journal of Cutaneous Pathology, Vol. 45, No. 8, 01.08.2018, p. 563-580.

Research output: Contribution to journalArticle

Vidal, CI, Armbrect, EA, Andea, AA, Bohlke, AK, Comfere, NI, Hughes, SR, Kim, J, Kozel, JA, Lee, JB, Linos, K, Litzner, BR, Missall, TA, Novoa, RA, Sundram, U, Swick, BL, Hurley, MY, Alam, M, Argenyi, Z, Duncan, LM, Elston, DM, Emanuel, PO, Ferringer, T, Fung, MA, Hosler, GA, Lazar, AJ, Lowe, L, Plaza, JA, Prieto, VG, Robinson, JK, Schaffer, A, Subtil, A & Wang, WL 2018, 'Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology', Journal of Cutaneous Pathology, vol. 45, no. 8, pp. 563-580. https://doi.org/10.1111/cup.13142
Vidal, Claudia I. ; Armbrect, Eric A. ; Andea, Aleodor A. ; Bohlke, Angela K. ; Comfere, Nneka I. ; Hughes, Sarah R. ; Kim, Jinah ; Kozel, Jessica A. ; Lee, Jason B. ; Linos, Konstantinos ; Litzner, Brandon R. ; Missall, Tricia A. ; Novoa, Roberto A. ; Sundram, Uma ; Swick, Brian L. ; Hurley, Maria Yadira ; Alam, Murad ; Argenyi, Zsolt ; Duncan, Lyn M. ; Elston, Dirk M. ; Emanuel, Patrick O. ; Ferringer, Tammie ; Fung, Maxwell A ; Hosler, Gregory A. ; Lazar, Alexander J. ; Lowe, Lori ; Plaza, Jose A. ; Prieto, Victor G. ; Robinson, June K. ; Schaffer, Andras ; Subtil, Antonio ; Wang, Wei Lien. / Appropriate use criteria in dermatopathology : Initial recommendations from the American Society of Dermatopathology. In: Journal of Cutaneous Pathology. 2018 ; Vol. 45, No. 8. pp. 563-580.
@article{ccb1c0e901924d6cbc5003f8fa63c72c,
title = "Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology",
abstract = "Background: Appropriate use criteria (AUC) provide physicians guidance in test selection, and can affect health care delivery, reimbursement policy and physician decision-making. Objectives: The American Society of Dermatopathology, with input from the American Academy of Dermatology and the College of American Pathologists, sought to develop AUC in dermatopathology. Methods: The RAND/UCLA appropriateness methodology, which combines evidence-based medicine, clinical experience and expert judgment, was used to develop AUC in dermatopathology. Results: With the number of ratings predetermined at 3, AUC were developed for 211 clinical scenarios involving 12 ancillary studies. Consensus was reached for 188 (89{\%}) clinical scenarios, with 93 (44{\%}) considered “usually appropriate,” 52 (25{\%}) “rarely appropriate” and 43 (20{\%}) “uncertain appropriateness.”. Limitations: The methodology requires a focus on appropriateness without comparison between tests and irrespective of cost. Conclusions: The ultimate decision of when to order specific test rests with the physician and is one where the expected benefit exceeds the negative consequences. This publication outlines the recommendations of appropriateness—AUC for 12 tests used in dermatopathology. Importantly, these recommendations may change considering new evidence. Results deemed “uncertain appropriateness” and where consensus was not reached may benefit from further research.",
keywords = "ancillary studies, appropriate use criteria, dermatopathology, evidence-based medicine, expert rating",
author = "Vidal, {Claudia I.} and Armbrect, {Eric A.} and Andea, {Aleodor A.} and Bohlke, {Angela K.} and Comfere, {Nneka I.} and Hughes, {Sarah R.} and Jinah Kim and Kozel, {Jessica A.} and Lee, {Jason B.} and Konstantinos Linos and Litzner, {Brandon R.} and Missall, {Tricia A.} and Novoa, {Roberto A.} and Uma Sundram and Swick, {Brian L.} and Hurley, {Maria Yadira} and Murad Alam and Zsolt Argenyi and Duncan, {Lyn M.} and Elston, {Dirk M.} and Emanuel, {Patrick O.} and Tammie Ferringer and Fung, {Maxwell A} and Hosler, {Gregory A.} and Lazar, {Alexander J.} and Lori Lowe and Plaza, {Jose A.} and Prieto, {Victor G.} and Robinson, {June K.} and Andras Schaffer and Antonio Subtil and Wang, {Wei Lien}",
year = "2018",
month = "8",
day = "1",
doi = "10.1111/cup.13142",
language = "English (US)",
volume = "45",
pages = "563--580",
journal = "Journal of Cutaneous Pathology",
issn = "0303-6987",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Appropriate use criteria in dermatopathology

T2 - Initial recommendations from the American Society of Dermatopathology

AU - Vidal, Claudia I.

AU - Armbrect, Eric A.

AU - Andea, Aleodor A.

AU - Bohlke, Angela K.

AU - Comfere, Nneka I.

AU - Hughes, Sarah R.

AU - Kim, Jinah

AU - Kozel, Jessica A.

AU - Lee, Jason B.

AU - Linos, Konstantinos

AU - Litzner, Brandon R.

AU - Missall, Tricia A.

AU - Novoa, Roberto A.

AU - Sundram, Uma

AU - Swick, Brian L.

AU - Hurley, Maria Yadira

AU - Alam, Murad

AU - Argenyi, Zsolt

AU - Duncan, Lyn M.

AU - Elston, Dirk M.

AU - Emanuel, Patrick O.

AU - Ferringer, Tammie

AU - Fung, Maxwell A

AU - Hosler, Gregory A.

AU - Lazar, Alexander J.

AU - Lowe, Lori

AU - Plaza, Jose A.

AU - Prieto, Victor G.

AU - Robinson, June K.

AU - Schaffer, Andras

AU - Subtil, Antonio

AU - Wang, Wei Lien

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Background: Appropriate use criteria (AUC) provide physicians guidance in test selection, and can affect health care delivery, reimbursement policy and physician decision-making. Objectives: The American Society of Dermatopathology, with input from the American Academy of Dermatology and the College of American Pathologists, sought to develop AUC in dermatopathology. Methods: The RAND/UCLA appropriateness methodology, which combines evidence-based medicine, clinical experience and expert judgment, was used to develop AUC in dermatopathology. Results: With the number of ratings predetermined at 3, AUC were developed for 211 clinical scenarios involving 12 ancillary studies. Consensus was reached for 188 (89%) clinical scenarios, with 93 (44%) considered “usually appropriate,” 52 (25%) “rarely appropriate” and 43 (20%) “uncertain appropriateness.”. Limitations: The methodology requires a focus on appropriateness without comparison between tests and irrespective of cost. Conclusions: The ultimate decision of when to order specific test rests with the physician and is one where the expected benefit exceeds the negative consequences. This publication outlines the recommendations of appropriateness—AUC for 12 tests used in dermatopathology. Importantly, these recommendations may change considering new evidence. Results deemed “uncertain appropriateness” and where consensus was not reached may benefit from further research.

AB - Background: Appropriate use criteria (AUC) provide physicians guidance in test selection, and can affect health care delivery, reimbursement policy and physician decision-making. Objectives: The American Society of Dermatopathology, with input from the American Academy of Dermatology and the College of American Pathologists, sought to develop AUC in dermatopathology. Methods: The RAND/UCLA appropriateness methodology, which combines evidence-based medicine, clinical experience and expert judgment, was used to develop AUC in dermatopathology. Results: With the number of ratings predetermined at 3, AUC were developed for 211 clinical scenarios involving 12 ancillary studies. Consensus was reached for 188 (89%) clinical scenarios, with 93 (44%) considered “usually appropriate,” 52 (25%) “rarely appropriate” and 43 (20%) “uncertain appropriateness.”. Limitations: The methodology requires a focus on appropriateness without comparison between tests and irrespective of cost. Conclusions: The ultimate decision of when to order specific test rests with the physician and is one where the expected benefit exceeds the negative consequences. This publication outlines the recommendations of appropriateness—AUC for 12 tests used in dermatopathology. Importantly, these recommendations may change considering new evidence. Results deemed “uncertain appropriateness” and where consensus was not reached may benefit from further research.

KW - ancillary studies

KW - appropriate use criteria

KW - dermatopathology

KW - evidence-based medicine

KW - expert rating

UR - http://www.scopus.com/inward/record.url?scp=85049828855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049828855&partnerID=8YFLogxK

U2 - 10.1111/cup.13142

DO - 10.1111/cup.13142

M3 - Article

VL - 45

SP - 563

EP - 580

JO - Journal of Cutaneous Pathology

JF - Journal of Cutaneous Pathology

SN - 0303-6987

IS - 8

ER -